Abstract

We propose a framework for the treatment, rehabilitation, and research into Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) using a natural history of disease approach to outline the distinct disease stages, with an emphasis on cases following infection to provide insights into prevention. Moving away from the method of subtyping patients based on the various phenotypic presentations and instead reframing along the lines of disease progression could help with defining the distinct stages of disease, each of which would benefit from large prospective cohort studies to accurately describe the pathological mechanisms taking place therein. With a better understanding of these mechanisms, management and research can be tailored specifically for each disease stage. Pre-disease and early disease stages call for management strategies that may decrease the risk of long-term morbidity, by focusing on avoidance of further insults, adequate rest to enable recovery, and pacing of activities. Later disease stages require a more holistic and tailored management approach, with treatment—as this becomes available—targeting the alleviation of symptoms and multi-systemic dysfunction. More stringent and standardised use of case definitions in research is critical to improve generalisability of results and to create the strong evidence-based policies for management that are currently lacking in ME/CFS.

Highlights

  • Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a complex disease of unknown aetiology with no diagnostic test or biomarker to enable accurate and timely identification of cases [1]

  • We argue that the proposed framework will help to target the public health, clinical, and research efforts in ME/CFS in more effective ways, recognising that it will likely be improved by future research findings

  • As we focus on the cellular level of molecular and systems medicine and transfer knowledge acquired from other conditions, we should get closer to finding the real explanations for the various subgroups in ME/CFS

Read more

Summary

Introduction

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a complex disease of unknown aetiology with no diagnostic test or biomarker to enable accurate and timely identification of cases [1]. We intend to outline the stages of this disease for the optimisation of treatment, rehabilitation, and research into ME/CFS by considering specific preventative measures, improving generalisability of results, and creating the strong evidence-based policies for management that are currently lacking in ME/CFS.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call